Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.
State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Stephen L
SL
Chan
Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Anthony W H
AW
Chan
D001323:Autoantibodies / Q000097:blood* / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D019698:Hepatitis C, Chronic / Q000473:pathology*; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins / Q000276:immunology*; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000276:immunology*
D001323:Autoantibodies; D014408:Biomarkers, Tumor; D009419:Nerve Tissue Proteins; D044925:Oxidoreductases Acting on CH-CH Group Donors; C499055:DHCR24 protein, human
Biomarker; Liver neoplasm; Surveillance